Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;66(1):58-65.
doi: 10.4187/respcare.07712. Epub 2020 Sep 1.

Preserved Ratio Impaired Spirometry in a Spirometry Database

Affiliations

Preserved Ratio Impaired Spirometry in a Spirometry Database

Andrei Schwartz et al. Respir Care. 2021 Jan.

Abstract

Background: Spirometry results can yield a diagnosis of normal air flow, air flow obstruction, or preserved ratio impaired spirometry (PRISm), defined as a reduced FEV1 or FVC in the setting of preserved FEV1/FVC. Previous studies have estimated the prevalence of PRISm to be 7-12%. Our objective was to examine the prevalence of PRISm in a spirometry database and to identify factors associated with PRISm.

Methods: We performed a retrospective analysis of 21,870 spirometries; 1,616 were excluded because of missing data or extremes of age, height, or weight. We calculated the prevalence of PRISm in prebronchodilator and postbronchodilator pulmonary function tests. Subsequently, we calculated the prevalence of PRISm by various age, race, body mass index, and diagnosis categories, as well as by gender and smokers versus nonsmokers. Finally, in the subset of the cohort with FEV1 < lower limit of normal, we performed a multivariable logistic regression analysis to identify factors associated with PRISm.

Results: We identified 18,059 prebronchodilator spirometries, and 22.3% of these yielded a PRISm diagnosis. This prevalence remained stable in postbronchodilator spirometries (17.7%), after excluding earlier pulmonary function tests for subjects with multiple pulmonary function tests (20.7% in prebronchodilator and 24.3% in postbronchodilator), and when we limited the analysis to prebronchodilator spirometries that met American Thoracic Society criteria (20.6%). The PRISm prevalence was higher in subjects 45-60 y old (24.4%) and in males (23.7%) versus females (17.9%). The prevalence rose with body mass index and was higher for those with a referral diagnosis of restrictive lung disease (50%). PRISm prevalence was similar between races and smokers versus nonsmokers. In a multivariable analysis, higher % of predicted FEV1 (odds ratio 1.51, 95% CI 1.42-1.60), body mass index (odds ratio 1.52, 95% CI 1.39-1.68), and restrictive lung disease (odds ratio 4.32, 95% CI 2.54-7.57) were associated with a diagnosis of PRISm. Smoking was inversely associated (odds ratio 0.55, 95% CI 0.46-0.65) with PRISm.

Conclusions: In a spirometry database at an academic medical center, the PRISm prevalence was 17-24%, which is higher than previously reported.

Keywords: chronic obstructive pulmonary disease; lung volume measurements; plethysmography; preserved ratio impaired spirometry (PRISm); respiratory function tests; spirometry.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Flow chart. PFT = pulmonary function tests; ATS = American Thoracic Society.
Fig. 2.
Fig. 2.
Subgroup analysis of preserved ratio impaired spirometry (PRISm) based on age, sex, and smoking status. * P < 0.01 between 45–60 year old and all other age groups, P < 0.01 between female and male sex.
Fig. 3.
Fig. 3.
Subgroup analysis of preserved ratio impaired spirometry (PRISm) based on body mass index, diagnosis category, and lung volumes. * P < 0.01 between obese and low-normal/overweight, P < 0.01 between very obese and all other weight groups, P < 0.01 between obstructive and none, § P < 0.01 between restrictive and all other PFT patterns.

References

    1. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD, et al. . Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 2010;65(6):499–504. - PMC - PubMed
    1. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003;58(5):388–393. - PMC - PubMed
    1. Mannino DM, Doherty DE, Buist AS. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006;100(1):115–122. - PubMed
    1. Wan ES, Fortis S, Regan EA, Hokanson J, Han MK, Casaburi R, et al. . Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med 2018;198(11):1397–1405. - PMC - PubMed
    1. Wan ES, Castaldi PJ, Cho MH, Hokanson JE, Regan EA, Make BJ, et al. . Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res 2014;15(1):89. - PMC - PubMed